MOXIFLOXACIN HCL 400 MG TABLET
For 30 tablets
Pharmacies pay
$40.12 filed
30 × $1.33723 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$117.71 filed
30 × $3.92378 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
2.9× estimated
Medicare paid 2.9× what pharmacies pay.
Part D averages every strength and form sold under “Moxifloxacin HCl” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$51.14 estimated
$40.12 + $6.02 (15%) + $5.00 fee per fill = $51.14
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
MOXIFLOXACIN HCL 400 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “moxifloxacin hydrochloride” and “moxifloxacin hydrochloride tablets, 400 mg”, as its NDCs’ listings variously write the nonproprietary name, under the trade name “Moxifloxacin”.
FDA gives its dosage form as tablet, film coated and its route as oral.
FDA lists 7 labelers (the companies named on the label) for its NDCs, among them Major Pharmaceuticals, AvPAK and Rising Pharma Holdings, Inc.
FDA lists it under 2 Established Pharmacologic Classes: Fluoroquinolone Antibacterial and Quinolone Antimicrobial.
The NADAC file of 2026-10-14 prices it under 11 NDCs (National Drug Codes); the FDA directory lists 8 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $40.12 for 30 tablets (30 × $1.33723 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 7 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Major Pharmaceuticals | 2 | $1.33723 per EA filed |
| American Health Packaging | 1 | $1.33723 per EA filed |
| Aurobindo Pharma Limited | 1 | $1.33723 per EA filed |
| AvPAK | 1 | $1.33723 per EA filed |
| Novadoz Pharmaceuticals LLC | 1 | $1.33723 per EA filed |
| Rising Pharma Holdings, Inc. | 1 | $1.33723 per EA filed |
| Solaris Pharma Corporation | 1 | $1.33723 per EA filed |
| Not listed as a package in the FDA directory | 3 | $1.33723 per EA filed |
All 11 NDCs, with labeler and price
- 00093-7387-56 · not listed as a package in the FDA directory · $1.33723 per EA · eff. 2026-09-23 filed
- 00904-7407-04 · Major Pharmaceuticals · $1.33723 per EA · eff. 2026-09-23 filed
- 00904-7407-06 · Major Pharmaceuticals · $1.33723 per EA · eff. 2026-09-23 filed
- 50268-0576-11 · not listed as a package in the FDA directory · $1.33723 per EA · eff. 2026-09-23 filed
- 50268-0576-13 · AvPAK · $1.33723 per EA · eff. 2026-09-23 filed
- 57237-0156-30 · Rising Pharma Holdings, Inc. · $1.33723 per EA · eff. 2026-09-23 filed
- 65862-0603-30 · Aurobindo Pharma Limited · $1.33723 per EA · eff. 2026-09-23 filed
- 68084-0722-11 · not listed as a package in the FDA directory · $1.33723 per EA · eff. 2026-09-23 filed
- 68084-0722-65 · American Health Packaging · $1.33723 per EA · eff. 2026-09-23 filed
- 72205-0001-30 · Novadoz Pharmaceuticals LLC · $1.33723 per EA · eff. 2026-09-23 filed
- 73473-0903-30 · Solaris Pharma Corporation · $1.33723 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
2 other products in the NADAC file share an FDA nonproprietary name with MOXIFLOXACIN HCL 400 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| MOXIFLOXACIN 0.5% EYE DROPS | $1.59631 per ML filed | We don’t know yet |
| MOXIFLOXACIN HCL 400 MG TABLET this page | $1.33723 per EA filed | $3.92378 per EA filed |
| VIGAMOX 0.5% EYE DROPS | $31.808 per ML filed | $60.70401 per ML filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-06-17, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 11 NDCs’ NADAC prices is $1.33723 per EA filed.
Of the 4 other products in FDA’s Fluoroquinolone Antibacterial class priced per EA, 1 has a higher middle NADAC price and 3 a lower one. The one in the middle is CIPROFLOXACIN HCL 500 MG TAB, at $0.12284 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $117.71 for 30 tablets, at an average of $3.92378 per EA in 2024 (2024-01-01 to 2024-12-31) for “Moxifloxacin HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 64,055 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
10 of the product’s 11 NDCs have this Medicare figure; the other 1 do not, and the interactive card says why for each.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for MOXIFLOXACIN HCL 400 MG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Moxifloxacin HCl / Moxifloxacin HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
Related pages
Its pharmacologic classes
Related in the same class
- CIPROFLOXACIN 0.3% EYE DROP
- OFLOXACIN 0.3% EYE DROPS
- BESIVANCE 0.6% SUSP
- GATIFLOXACIN 0.5% EYE DROPS
- CIPRO HC OTIC SUSPENSION